Candidate Luminal B Breast Cancer Genes Identified by Genome, Gene Expression and DNA Methylation Profiling

Intrinsic breast cancer subtypes defined by estrogen receptor signalling—prognostic relevance of progesterone receptor loss

(2013) Lisa Braun et al.   MODERN PATHOLOGY

Luminal breast cancer: from biology to treatment

(2013) Michail Ignatiadis et al.   Nature Reviews Clinical Oncology

RecQL4 Helicase Amplification Is Involved in Human Breast Tumorigenesis

(2013) Hongbo Fang et al.   PLoS One

Progesterone receptor loss identifies Luminal B breast cancer subgroups at higher risk of relapse

(2012) G. Cancello et al.   ANNALS OF ONCOLOGY

TLX Homeodomain Oncogenes Mediate T Cell Maturation Arrest in T-ALL via Interaction with ETS1 and Suppression of TCRα Gene Expression

(2012) Saïda Dadi et al.   CANCER CELL

A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets

(2012) Niantao Deng et al.   GUT

Protein pathway activation mapping reveals molecular networks associated with antiestrogen resistance in breast cancer cell lines

(2012) Ton van Agthoven et al.   INTERNATIONAL JOURNAL OF CANCER

Genomic Predictors of Outcome and Treatment Response in Breast Cancer

(2012) Lara Dunn et al.   Molecular Diagnosis & Therapy

Sequence analysis of mutations and translocations across breast cancer subtypes

(2012) Shantanu Banerji et al.   NATURE

Comprehensive molecular portraits of human breast tumours

(2012) Daniel C. Koboldt et al.   NATURE

Objective assessment of cancer genes for drug discovery

(2012) Mishal N. Patel et al.   NATURE REVIEWS DRUG DISCOVERY

Mutations and deletions of ARID1A in breast tumors

(2012) S Cornen et al.   ONCOGENE

FOXM1: From cancer initiation to progression and treatment

(2011) Chuay-Yeng Koo et al.   Biochimica et Biophysica Acta-Gene Regulatory Mechanisms

Identification of gene fusion transcripts by transcriptome sequencing in BRCA1-mutated breast cancers and cell lines

(2011) Kevin CH Ha et al.   BMC Medical Genomics

Gene expression profiling of luminal B breast cancers reveals NHERF1 as a new marker of endocrine resistance

(2011) Thomas Karn et al.   BREAST CANCER RESEARCH AND TREATMENT

FOXO3a nuclear localisation is associated with good prognosis in luminal-like breast cancer

(2011) Hany Onsy Habashy et al.   BREAST CANCER RESEARCH AND TREATMENT

Genome-Wide DNA Methylation Profiling of CpG Islands in Breast Cancer Identifies Novel Genes Associated with Tumorigenicity

(2011) V. K. Hill et al.   CANCER RESEARCH

Genome-wide Methylation Analysis Identifies Genes Specific to Breast Cancer Hormone Receptor Status and Risk of Recurrence

(2011) M. J. Fackler et al.   CANCER RESEARCH

ZNF703is a common Luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epithelium

(2011) Daniel G. Holland et al.   EMBO Molecular Medicine

ZNF703gene amplification at 8p12 specifies luminal B breast cancer

(2011) Fabrice Sircoulomb et al.   EMBO Molecular Medicine

High-resolution genomic analysis of the 11q13 amplicon in breast cancers identifies synergy with 8p12 amplification, involving the mTOR targets S6K2 and 4EBP1

(2011) Elin Karlsson et al.   GENES CHROMOSOMES & CANCER

Micelle-Encapsulated Thiostrepton as an Effective Nanomedicine for Inhibiting Tumor Growth and for Suppressing FOXM1 in Human Xenografts

(2011) M. Wang et al.   MOLECULAR CANCER THERAPEUTICS

RUNX3 acts as a tumor suppressor in breast cancer by targeting estrogen receptor α

(2011) B Huang et al.   ONCOGENE

High-Resolution Comparative Genomic Hybridization of Inflammatory Breast Cancer and Identification of Candidate Genes

(2011) Ismahane Bekhouche et al.   PLoS One

Identification of fusion genes in breast cancer by paired-end RNA-sequencing

(2011) Henrik Edgren et al.   GENOME BIOLOGY

Genome profiling of ERBB2-amplified breast cancers

(2010) Fabrice Sircoulomb et al.   BMC CANCER

FGFR1 Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer

(2010) N. Turner et al.   CANCER RESEARCH

Integration of DNA Copy Number Alterations and Prognostic Gene Expression Signatures in Breast Cancer Patients

(2010) H. M. Horlings et al.   CLINICAL CANCER RESEARCH

Breast cancer molecular profiling with single sample predictors: a retrospective analysis

(2010) Britta Weigelt et al.   LANCET ONCOLOGY

Loss, mutation and deregulation of L3MBTL4 in breast cancers

(2010) Lynda Addou-Klouche et al.   Molecular Cancer

Array-Based DNA Methylation Profiling for Breast Cancer Subtype Discrimination

(2010) Ilse Van der Auwera et al.   PLoS One

Molecular Characterization of Breast Cancer with High-Resolution Oligonucleotide Comparative Genomic Hybridization Array

(2009) F. Andre et al.   CLINICAL CANCER RESEARCH

Circos: An information aesthetic for comparative genomics

(2009) M. Krzywinski et al.   GENOME RESEARCH

Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes

(2009) Joel S. Parker et al.   JOURNAL OF CLINICAL ONCOLOGY

Gene-Expression Signatures in Breast Cancer

(2009) Christos Sotiriou et al.   NEW ENGLAND JOURNAL OF MEDICINE

Co-amplified genes at 8p12 and 11q13 in breast tumors cooperate with two major pathways in oncogenesis

(2009) S S Kwek et al.   ONCOGENE

Characterization of the Recurrent 8p11-12 Amplicon Identifies PPAPDC1B, a Phosphatase Protein, as a New Therapeutic Target in Breast Cancer

(2008) I. Bernard-Pierrot et al.   CANCER RESEARCH

Integrated Genomic and Transcriptomic Analysis of Ductal Carcinoma In situ of the Breast

(2008) A. Vincent-Salomon et al.   CLINICAL CANCER RESEARCH

Combinatorial patterns of somatic gene mutations in cancer

(2008) Chen-Hsiang Yeang et al.   FASEB JOURNAL